Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Healthcare Medical Devices
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical... see more

Recent & Breaking News (TSXV:THRM)

Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med

Newsfile 4 days ago

Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

Newsfile December 18, 2025

Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors

Newsfile October 10, 2025

Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales

Newsfile September 24, 2025

Therma Bright Proposes to Amend Certain Warrants

Newsfile August 28, 2025

Therma Bright Announces Share Consolidation

Newsfile July 3, 2025

Therma Bright Inc. Announces Share Consolidation

Newsfile June 11, 2025

Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements

Newsfile June 5, 2025

Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin

Newsfile May 8, 2025

Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence

Newsfile April 24, 2025

Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes

Newsfile April 16, 2025

Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC

Newsfile March 13, 2025

Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board

Newsfile February 4, 2025

Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN

Newsfile January 21, 2025

Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio

Newsfile January 13, 2025

Therma Bright Announces Shares for Debt Issuance

Newsfile January 9, 2025

Therma Bright Announces Shares for Debt Issuance

Newsfile January 3, 2025

Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority

Newsfile December 18, 2024

Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase

Newsfile December 11, 2024

Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days

Newsfile December 5, 2024

Podcasts